营养保健品和疫苗市场规模、份额和增长分析（按产品类型、应用、配方类型、分销渠道和地区）- 2025-2032 年行业预测

2023 年全球膳食补充剂和疫苗市场规模价值 570.4 亿美元，预计将从 2024 年的 613.8 亿美元增长到 2032 年的 1102.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.6%。

受消费者意识增强和对健康和保健日益关注的推动，全球膳食补充剂和疫苗市场正在经历强劲增长。营养保健食品，包括机能性食品和膳食补充剂，因其预防性保健功效而越来越受到追捧。同时，在疫苗技术进步和世卫组织全球疫苗行动计划等鼓励全民接种疫苗的倡议支持的综合免疫计划的推动下，疫苗行业正在蓬勃发展。在政府和非政府组织的支持下，疫苗接种的激增正在增强整体公共卫生能力并推动市场成长。膳食补充剂在预防高血压和糖尿病等疾病方面发挥着重要作用，其需求不断增加，反映了社会向主动健康管理的转变，最终导致医疗成本降低和健康状况改善。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析

营养保健品和疫苗市场规模（按产品类型和复合年增长率） (2025-2032)

• 市场概况
• 疫苗
• 营养补充品

营养保健品和疫苗市场规模（按应用和复合年增长率） (2025-2032)

• 市场概况
• 运动营养
• 一般健康
• 免疫和消化健康
• 骨骼和关节健康
• 心臟健康
• 疾病预防
• 体重减轻

营养保健品和疫苗市场规模（按配方类型和复合年增长率） (2025-2032)

• 市场概况
• 药片
• 胶囊
• 粉末
• 液体

保健食品和疫苗市场规模（按分销管道和复合年增长率） (2025-2032)

• 市场概况
• 医院药房
• 零售药局
• 网上销售
• 超级市场

营养保健品及疫苗市场规模（依地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• GlaxoSmithKline plc（GSK）（United Kingdom）
• Pfizer Inc.（United States）
• Sanofi Pasteur（France）
• Merck & Co., Inc.（United States）
• Moderna, Inc.（United States）
• Novavax, Inc.（United States）
• CSL Limited（Australia）
• AstraZeneca plc（United Kingdom）
• Johnson & Johnson（United States）
• Bavarian Nordic A/S（Denmark）

结论和建议

Global Nutraceutical &Vaccine Market size was valued at USD 57.04 billion in 2023 and is poised to grow from USD 61.38 billion in 2024 to USD 110.28 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

The global nutraceutical and vaccine market is experiencing robust growth propelled by heightened consumer awareness and a growing focus on health and wellness. Nutraceuticals, including functional foods and dietary supplements, are increasingly sought after for their preventive health benefits. Simultaneously, the vaccine sector is booming due to advancements in vaccine technology and comprehensive immunization programs, supported by initiatives like WHO's Global Vaccine Action Plan, which encourages universal vaccination access. This surge in immunization, backed by both government and NGO involvement, is enhancing overall public health and fostering market growth. The increasing demand for nutraceuticals, recognized for their role in preventing diseases such as hypertension and diabetes, mirrors society's shift towards proactive health management, ultimately reducing healthcare costs and promoting well-being.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nutraceutical &Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nutraceutical &Vaccine Market Segments Analysis

Global Nutraceutical & Vaccine Market is segmented by Product Type, Application, Formulation Type, Distribution Channel and region. Based on Product Type, the market is segmented into Vaccines and Dietary Supplements. Based on Application, the market is segmented into Sports Nutrition, General Well-Being, Immune & Digestive Health, Bone & Joint Health, Heart Health, Disease Prevention and Weight loss. Based on Formulation Type, the market is segmented into Tablets, Capsules, Powders and Liquids. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Sales and Super Markets. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nutraceutical &Vaccine Market

A key driver in the global nutraceutical and vaccine market is the heightened focus on preventive healthcare. As awareness of the significance of overall well-being and disease prevention expands, there is a growing demand for products that provide health benefits and bolster the immune system. Consumers are increasingly turning to nutraceuticals and vaccines to adopt a proactive approach to their health. This trend is propelled by various factors, including changing lifestyles, an aging population, and the collective desire to cut healthcare costs by prioritizing disease prevention over treatment. This shift underscores the market's potential for growth and innovation.

Restraints in the Global Nutraceutical &Vaccine Market

A significant challenge facing the global nutraceutical and vaccine market is the stringent regulatory frameworks and approval processes that govern their development and commercialization. These regulations mandate extensive testing, clinical trials, and regulatory clearances to ensure that products meet required safety, efficacy, and quality standards. Such rigorous procedures can often be lengthy and expensive, creating obstacles for market participants, particularly smaller companies with constrained resources. Additionally, these stringent requirements can lead to delays in product launches and heightened compliance costs, ultimately stifling growth and innovation within the nutraceutical and vaccine industries.

Market Trends of the Global Nutraceutical &Vaccine Market

A significant market trend in the global nutraceutical and vaccine sector is the rising demand for personalized and targeted healthcare solutions. Consumers are becoming more health-conscious and are actively seeking products specifically designed to meet their unique health needs and genetic profiles. This trend is primarily driven by technological advancements in genomics, personalized medicine, and data analytics, enabling the creation of customized nutrition and vaccination options. Industry players are increasingly investing in the development of tailored nutraceuticals and vaccines, offering bespoke formulations that cater to individual health concerns and enhance therapeutic outcomes. This movement signifies a pivotal shift towards precision healthcare, acknowledging the importance of individual health variations.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Nutraceutical & Vaccine Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Vaccines
• Dietary Supplements

Global Nutraceutical & Vaccine Market Size by Application & CAGR (2025-2032)

• Market Overview
• Sports Nutrition
• General Well-Being
• Immune & Digestive Health
• Bone & Joint Health
• Heart Health
• Disease Prevention
• Weight loss

Global Nutraceutical & Vaccine Market Size by Formulation Type & CAGR (2025-2032)

• Market Overview
• Tablets
• Capsules
• Powders
• Liquids

Global Nutraceutical & Vaccine Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Sales
• Super Markets

Global Nutraceutical & Vaccine Market Size & CAGR (2025-2032)

• North America (Product Type, Application, Formulation Type, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Application, Formulation Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Formulation Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Formulation Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Formulation Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GlaxoSmithKline plc (GSK) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novavax, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations